Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Leelahavarong P"'
Autor:
Suphanchaimat R, Sommanustweechai A, Khitdee C, Thaichinda C, Kantamaturapoj K, Leelahavarong P, Jumriangrit P, Topothai T, Wisaijohn T, Putthasri W
Publikováno v:
HIV/AIDS: Research and Palliative Care, Vol 2014, Iss default, Pp 19-38 (2014)
Rapeepong Suphanchaimat,1,2 Angkana Sommanustweechai,1 Chiraporn Khitdee,1 Chompoonut Thaichinda,1 Kanang Kantamaturapoj,3 Pattara Leelahavarong,4 Pensom Jumriangrit,1 Thitikorn Topothai,1 Thunthita Wisaijohn,1 Weerasak Putthasri1 1International Heal
Externí odkaz:
https://doaj.org/article/64e9d78481f14eccb709ad8d36bbc820
Autor:
Polathep Vichitkunakorn, Roongnapa Khampang, Pattara Leelahavarong, Jiraluck Nontarak, Sawitri Assanangkornchai
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Road traffic injuries are a major concern worldwide, with Thailand facing high accident mortality rates. Drunk driving is a key factor that requires countermeasures. Random breath testing (RBT) and mass media campaigns recommended
Externí odkaz:
https://doaj.org/article/f6a5109138534e988677334db0b8784d
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2012, Iss default, Pp 361-374 (2012)
Thunyarat Anothaisintawee,1,2 Pattara Leelahavarong,1 Tanapat Ratanapakorn,3 Yot Teerawattananon11Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand; 2Family Medicine Department and Section of Clini
Externí odkaz:
https://doaj.org/article/6f1947c8e9b64382b7a3828583cdd9fc
Survival analysis and life expectancy of pediatric patients with spinal muscular atrophy in Thailand
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e32732- (2024)
Background: Survival data for Thai patients with 5q spinal muscular atrophy (SMA), the leading cause of infant mortality worldwide, are lacking. Objective: This study aimed to determine the survival rates and life expectancies of pediatric patients w
Externí odkaz:
https://doaj.org/article/757f52c8c7e740fb864fc261041f1bb1
Autor:
Tanawan Kongmalai, Phorntida Hadnorntun, Pattara Leelahavarong, Pinkawas Kongmalai, Varalak Srinonprasert, Srisakul Chirakarnjanakorn, Usa Chaikledkaew, Gareth McKay, John Attia, Ammarin Thakkinstian
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundIn patients with type 2 diabetes (T2D) and a history of heart failure (HF), sodium–glucose cotransporter-2 inhibitors (SGLT2is) have demonstrated cardiovascular (CV) benefits. However, the comparative efficacy of individual SGLT2is remain
Externí odkaz:
https://doaj.org/article/25b8826943474631b79f5fba120bfbed
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peerapatanapokin Wiwat, Namwat Chawetsan, Premsri Nakorn, Akaleephan Chutima, Werayingyong Pitsaphun, Teerawattananon Yot, Leelahavarong Pattara, Tangcharoensathien Viroj
Publikováno v:
BMC Public Health, Vol 11, Iss 1, p 534 (2011)
Abstract Background This study aims to determine the maximum price at which HIV vaccination is cost-effective in the Thai healthcare setting. It also aims to identify the relative importance of vaccine characteristics and risk behavior changes among
Externí odkaz:
https://doaj.org/article/99a709258d2142f1b56953e9c83c2972
Autor:
Kasemsup Vijj, Hongeng Suradej, Chaikledkaew Usa, Leelahavarong Pattara, Lubell Yoel, Teerawattananon Yot
Publikováno v:
BMC Health Services Research, Vol 10, Iss 1, p 209 (2010)
Abstract Background Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no
Externí odkaz:
https://doaj.org/article/af9af388a54a429b8aac28bc4ad0acce
Autor:
Juthamas Prawjaeng, Pattara Leelahavarong, Nuttakarn Budtarad, Songyot Pilasant, Chonticha Chanjam, Wanruchada Katchamart, Pongthorn Narongroeknawin, Tasanee Kitumnuaypong
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background New biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) all showed greater clinical benefits in the treatment of patients with rheumatoid arthritis (RA) w
Externí odkaz:
https://doaj.org/article/468a5c7f637b40ca804a284ffe446d81
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.